Buscar en
Acta Otorrinolaringológica Española
Toda la web
Inicio Acta Otorrinolaringológica Española Salivary Duct Carcinoma: Diagnostic Clues, Histology and Treatment
Journal Information
Vol. 64. Issue 2.
Pages 150-153 (March - April 2013)
Download PDF
More article options
Vol. 64. Issue 2.
Pages 150-153 (March - April 2013)
Case Study
Salivary Duct Carcinoma: Diagnostic Clues, Histology and Treatment
Carcinoma ductal salival: claves diagnósticas, histología y tratamiento
Elena Ponta,
Corresponding author

Corresponding author.
, Ángel Pláb, Julia Cruz Mojarrietac, Eduardo Ferrandisb, Simón Brotonsb, Juan B. Vendrellb
a Servicio de Otorrinolaringología, Hospital General de Castellón, Castellón, Spain
b Servicio de Otorrinolaringología, Fundación Instituto Valenciano de Oncología, Valencia, Spain
c Servicio de Anatomía Patológica, Fundación Instituto Valenciano de Oncología, Valencia, Spain
This item has received
Article information
Full Text
Download PDF
Figures (2)

Salivary duct carcinoma is a very rare, highly malignant epithelial tumour. We present a case of a 75-year-old man with a rapidly growing salivary duct carcinoma in the parotid gland, of one month's evolution. Histopathologically, salivary duct carcinoma is characterised by its resemblance to ductal carcinoma of the breast. It usually develops aggressively with possibilities of early distant metastasis and local recurrence. The tumour is managed with total parotidectomy, ipsilateral neck dissection and adjunctive radiation. In advanced cases, we recommend treatment with anti-Her-2 monoclonal antibodies such as trastuzumab.

Salivary duct carcinoma
Salivary neoplasm

El carcinoma ductal salival es un tumour epitelial de alto grado, muy poco frecuente. Presentamos el caso de un varón de 75 años con carcinoma ductal salival de rápido crecimiento, en la glándula parótida, de un mes de evolución. Histopatológicamente se caracteriza por su gran similitud con el carcinoma ductal de mama. Suele tener un comportamiento muy agresivo, con recurrencia local y metástasis a distancia tempranas, por lo que hay que realizar parotidectomía total con vaciamiento cervical ipsilateral y radioterapia adyuvante. En casos avanzados se recomienda tratamiento con anticuerpo monoclonal selectivo para el HER-2/neu como trastuzumab.

Palabras clave:
Carcinoma ductal salival
Neoplasias salivales


These are the options to access the full texts of the publication Acta Otorrinolaringológica Española

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe to

Acta Otorrinolaringológica Española

Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
No mostrar más